CCR2-V64I genetic polymorphism: a possible involvement in HER2+ breast cancer-Reference-Cited by-同舟云学术

CCR2-V64I genetic polymorphism: a possible involvement in HER2+ breast cancer

Published:2015-02-26 Issue:2 Volume:16 Page:139-145
ISSN:1591-9528
Container-title:Clinical and Experimental Medicine
language:en
Short-container-title:Clin Exp Med

Author:

Banin-Hirata Bruna Karina,Losi-Guembarovski Roberta,Oda Julie Massayo Maeda,de Oliveira Carlos Eduardo Coral,Campos Clodoaldo Zago,Mazzuco Tânia Longo,Borelli Sueli Donizete,Ceribelli Jesus Roberto,Watanabe Maria Angelica Ehara

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10238-015-0342-9.pdf

Reference37 articles.

1. Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [database on the Internet] 2012. Accessed: 25/01/2014.

2. Citri A, Skaria KB, Yarden Y. The deaf and the dumb: the biology of ErbB-2 and ErbB-3. Exp Cell Res. 2003;284(1):54–65.

3. de la Cruz-Merino L, Barco-Sanchez A, Carrasco FH et al. New insights into the role of the immune microenvironment in breast carcinoma. Clin Dev Immunol. 2013.

4. Charo IF, Myers SJ, Herman A, Franci C, Connolly AJ, Coughlin SR. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA. 1994;91(7):2752–6.

5. Sanders SK, Crean SM, Boxer PA, Kellner D, LaRosa GJ, Hunt SW. Functional differences between monocyte chemotactic protein-1 receptor A and monocyte chemotactic protein-1 receptor B expressed in a Jurkat T cell. J Immunol. 2000;165(9):4877–83.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significant association of MCP1 rs1024611 and CCR2 rs1799864 polymorphisms with colorectal cancer and liver metastases susceptibility and aggressiveness: A case-control study;Cytokine;2023-07

2. Effect of CCR2-V64I on the Susceptibility of Patients to Cancer;European Journal of Cancer Care;2023-06-23

3. Monocyte programming by cancer therapy;Frontiers in Immunology;2022-10-20

4. Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?;Cancers;2021-12-16

5. CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population;Frontiers in Immunology;2021-12-10